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Excess iron deposition in the substantia nigra (SN) has been linked to Parkinson’s disease (PD). 
Increased iron deposition may also be associated with PD duration and worsening motor 
impairment. Iron deposition in the SN and the almost inevitable progression to dementia in PD 
has not yet been investigated. Furthermore the link between PD with normal cognition (PD-N), 
those with mild cognitive impairment (PD-MCI) and dementia (PDD) and excess iron deposition 
in key grey matter nuclei of the basal ganglia (BG) other than the SN may be even more 
pertinent. In this thesis, I use a non-invasive, magnetic resonance imaging (MRI) methodology 
called quantitative susceptibility mapping (QSM) to indirectly estimate iron deposition in these 
grey matter nuclei and determine whether QSM values are associated with cognitive impairments 
in PD. 
A total of 121 subjects were recruited for this study. Extensive neuropsychological testing was 
used to characterize participants. Of these 31 were PD-N, 56 were PD-MCI, 10 were PDD and 24 
were age and sex matched healthy controls (HCs). Subjects were imaged using a multi-echo 
spoiled gradient echo. QSM was reconstructed from the raw images using non-linear morphology 
enabled dipole inversion and Laplacian boundary value background field removal. QSM values 
were extracted from the BG and red nucleus (RN) using two separate segmentations. Bayesian 
multi-level regression models were used to (1) test for differences between HCs and PD as a 
whole in each region of interest (ROI), and (2) to investigate any association between QSM 
values and cognitive impairment. Finally a whole brain analysis was performed to assess group 
differences on a voxel-by-voxel association between QSM values and cognitive score. 
Relative to controls, the PD group showed significantly higher QSM values in the SNc. There 
were no significant group differences in QSM values across the other basal ganglia structures 
investigated. For the category analysis the left SNc for PD-N was the only significant difference 
observed.  There was a weak positive correlation between the right RN and cognitive score with 
no other nuclei having any significant correlation. Whole brain analyses revealed no significant 
differences between the groups or association with cognition. 
In this thesis, I confirmed that increased QSM, and hence iron accumulation, in SNc in PD is a 
robust finding, consistent with previous imaging and pathological studies on PD, however this 
finding was limited to the ROI analysis. It appears from the evidence we have gathered that iron 
deposition does not affect cognitive functioning. In conclusion, this thesis established QSM in a 
population of PD patients. While the group association agreed with past studies this thesis hints a 
number of possible improvements and new directions to further investigate cognition and QSM. 
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Glossary of Terms 
α: flip angle 
δ: local magnetic field map 
χ: magnetic susceptibility 
B0: main magnetic field 
BFR: background field removal 
BG: basal ganglia  
CogZ: cognitive z-score 
DICOM: Digital Imaging and Communications in Medicine 
EM: electromagnetic 
FWHM: full width half maximum 
FSL: FMRIB Software Library 
GP: globus pallidus 
HC: healthy control 
LBV: Laplacian boundary value 
MDSTF: Movement Disorders Society Task Force 
MEDI: morphology enabled dipole inversion  
MNI: Montreal Neurological Institute 
MR: magnetic resonance 
MRI: magnetic resonance imaging 
Mxy: transverse magnetisation 
Mz: longitudinal magnetisation  
NIFTI: Neuroimaging Informatics Technology Initiative 
NZBRI: New Zealand Brain Research Institute 
PD: Parkinson’s disease 
PDF: projection onto dipole fields 
PD-MCI: mild cognitive impairment in Parkinson’s disease 
PDD: Parkinson’s disease dementia 
ppm: parts per million 
QS: quantitative susceptibility 
QSM: quantitative susceptibility mapping 
RF: radiofrequency 
ROI: region of interest  
SPGRE: spoiled gradient echo 
SPM: Statistical Parametric Mapping 
SN: substantia nigra 
SNc: substantia nigra pars compacta 
SNr: substantia nigra pars reticulata 
SNR: signal to noise ratio 
TE: echo time 
TR: repetition time. 




Chapter 1: Introduction 
1.01 Introduction to Parkinson ’s Disease & its Impact on Society 
Parkinson’s disease (PD) is a neurodegenerative disease that, like many diseases, is named after 
the man who first identified it, James Parkinson, in 1817 who originally called PD “Shaking 
Palsy” 
(1)
. He observed and noted the classic motor symptoms of PD; rest tremor of 4-6Hz, 
asymmetrical and insidious onset, Bradykinesia or slowness of movement, stiffness, flexed 
posture and a ‘festinating gait’ 
(1)
.  
PD has since been recognised as the second most common neurodegenerative disease in the 
world after Alzheimer’s 
(2)
. 3% of the New Zealand population over 65 years of age, 
approximately 10,000 individuals, are diagnosed with the disease 
(3)
. PD however is not exclusive 
to the elderly with 10% of PD patients in New Zealand being under the age of 40 
(3)
.  Currently 
16% of the population in New Zealand is over 65 and that is estimated to grow to 25% by the 
year 2041 
(4)
. With a growing ageing population caused by sub-replacement fertility, increasing 
life expectancy and the passage of baby boomers into retirement ages, PD is becoming an 
increasing burden in terms of the quality of life of its sufferers and their loved ones and in terms 
of the financial burden of the disease on the state 
(4)
. As a result there is increasing demand and 
pressure to develop treatments and interventions for PD and its subtypes 
(5)
. In a recent report 
from the Ministry of Health, the government voiced their concerns stating,  
“We may be living longer, and living longer in good health, but we are also living longer in poor 
health. Our health system and wider society have proved more adept at preventing early death 
than at avoiding or ameliorating morbidity. A greater focus on addressing the impact of non-fatal 
disabling conditions, whether through prevention or improved management, will enable people to 
live more of their ‘extra’ years of life in full health… Neuropsychiatric disorders are now the 
leading cause of health loss, accounting for 19% of total disability-affected life years (DALYs).” 
(5)
  
In an ironic twist it was found that improving healthcare actually increased the cost of healthcare 
expenditure rather than decreased it due to the population living longer in morbidity
 (5)
. 
1.02 Parkinson’s Disease Anatomy and Physiology 
In order to understand Parkinson’s disease one must first understand the basal ganglia (BG). The 
BG is a collection of grey matter nuclei that together help regulate the initiation and execution of 
voluntary movement and thought 
(6)
. The primary components of the BG are the caudate nucleus, 
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the putamen, the globus pallidus (GP), the thalamus and the substantia nigra (SN) (fig. 1.01) 
(6)
. 
The SN and GP are further divided into two segments, the SN pars compacta (SNc) and pars 
reticulata (SNr) and the internal and external globus pallidus (fig. 1.01) 
(6)
. 
The SNc provides the caudate nucleus and 
putamen (collectively called the dorsal 
striatum) with the neurotransmitter dopamine 
(6)
. The SNc isn’t the only provider of 
dopamine in the brain, but it is the only group 
of neurones that provides the dorsal striatum 
with dopamine 
(6)
. Dopamine has affinities for 
specific G-protein-coupled receptor sites found 
in the dorsal striatum 
(6)
. Binding to these 
receptor sites either inhibits or excites adenylyl 
cyclase, which in turn contributes to a large 
number of complex behaviours 
(6)
. The dorsal 
striatum primarily mediates motor function, 
specifically the inhibition and initiation of 
voluntary motor pathways 
(6)
 and also is 
involved in some prefrontal and limbic neural 
loops, which control or contribute to a wide 




PD is associated with the death of neurones in 
the SNc 
(6)
. The subsequent lack of dopamine causes the motor symptoms attributed to PD, 
however dopamine produced by SNc is also involved in a variety of complex cognitive, thought, 
mood and behavioural functions, which are also impacted 
(6)
. Examples of non-motor symptoms 
related to PD include, REM sleep disturbance, sensory deficits particularly smell, depression, 
anxiety, speech deficits and cognitive deficits such as deficits in learning, attention, memory, 
working memory, judgment and evaluation, reasoning, problem solving and decision making, 
planning, visuospatial processing, cognitive flexibility and abstract thinking 
(6)
. SNc cell loss has 
only been attributed to some of these functions and it is thought that the degradation of other 
nuclei in the BG may account for the rest of these non-motor symptoms. 
Figure 1.01: Anatomy of the basal ganglia (BG) 
(6)
. The 
BG is primarily comprised of the caudate nucleus, 
putamen, globus pallidus (GP), thalamus and 
substantia nigra (SN) which lie just below the 
subthalamic nuclei. The GP is further divided into two 
segments, the internal and external GP and the SN, 
into the pars compacta (SNc) and pars reticulata (SNr) 
(6)
. The SNc supplies the caudate nucleus and putamen 
with the neurotransmitter dopamine allowing the BG 






The main cause of SNc cell loss is still largely unknown or idiopathic and it is not known exactly 
what causes these dopaminergic neurones to undergo apoptosis or programmed cell death 
(6)
. 
Mutations of three distinct genes; PINK-1,  DJ-1 and Parkin have been found to cause PD, but 
only in rare cases and they account for a very small minority, less than 1% 
(6, 7)
. Cell death has 
been associated with metabolic dysfunction and abnormalities in the mitochondrial complex-1 
gene, which is the primary difference between the SNc and the other dopaminergic regions of the 
brain that don’t undergo spontaneous cell death 
(8)
. It is proposed that SNc is also particularly 
vulnerable to the aggregation and accumulation of α-synuclein proteins, due to possessing long, 
thin and poorly myelinated axons, which has become the pathological hallmark of the disease 
(9)
. 
Another signature of PD is iron deposition. The first link between iron deposition in the brain and 
PD was noted in 1987 when Dexter et al identified an abnormally high iron content of the SNc in 
post mortem brains of people who had died as a result of PD 
(10)
. Iron is a cofactor in the 
production of L-DOPA, the immediate precursor to dopamine however excess iron can produce 
harmful free radicals 
(11)
. Iron accumulation in PD has been found to cause harmful oxidative 
stress, metabolic dysfunction and promotion of α-synuclein aggregation that could be the primary 
cause of neuronal cell death 
(12, 13)
. It is unclear however as to whether improper regulation of iron 
transport and storage is the cause of accumulation or whether it is a consequence of 
neurodegeneration initiated by other means. 
1.03 Cognitive Impairment in Parkinson’s Disease 
Many patients with PD will also develop cognitive impairments, in addition to their motor 
symptoms. Relatively minor cognitive impairment is referred to as mild cognitive impairment in 
PD (PD-MCI) 
(14)
. Some PD-MCI patients may experience visual hallucinations along with 
further sudden decline in multiple areas of cognition, which if significantly impacted, will result 
in dementia (known as PD dementia or PDD) 
(15)
.  PD-MCI is graded between normal cognition 
and dementia using several different continuous measures 
(14)
.  
Although much is known about the effects of PD on the motor system, less is known about the 
link between PD, cognitive impairment and the resultant development of dementia 
(14)
. Currently 
the motor symptoms of PD are treated with pharmaceuticals primarily L-DOPA (levodopa), the 
direct biological precursor to dopamine, which can cross the blood brain barrier where it is then 
converted to dopamine locally 
(11)
. This treatment is only effective in the early stages of the 
disease before the patient develops a tolerance and only replaces the lack of dopamine partially 
relieving the motor and some non-motor symptoms of the disease 
(11)
. Levodopa does not relieve 





curative treatment exists for cognitive impairment or dementia and the patients themselves have 
confirmed that cognitive deficiency is their primary concern with PD not the motor symptoms 
(16)
. PDD is now the primary cause of disability, caregiver burden, healthcare expenditure and 
mortality due to PD 
(16)
. A recent report from the Ministry of Health stressed the importance of 
improving care for dementia,  
“Dementia has risen to become the fifth-ranked cause of health loss in females and thirteenth in 
males. Providing better care for people living with mental illness, addiction and dementia – 




80% of PD patients will develop PDD at some stage of the disease’s progression as a direct result 
of PD itself, although the time at which a patient with PD transitions to PDD is highly variable 
and there is currently no method to predict exactly who will make the transition and when 
(16)
. 25-
62% of PD-MCI patients are at increased risk of developing dementia within 3 years, but not all 
PD-MCI patients are at imminent risk of dementia. This is important because the treatments and 
management of PD-MCI and PDD are different 
(17)
. It is proposed that levodopa contributes to the 
decline in cognition and wouldn’t be prescribed to PDD patients, however taking a PD-MCI 
patient off levodopa for the fear that they are at risk of developing dementia when they possibly 
won’t would be inhumane 
(17)
. In the future it may possible to treat dementia or slow its 
progression by introducing therapies prior to the decline from MCI to PDD. If some kind of 
intervention or therapy is to be developed to treat dementia one must be able to reliably predict 
who will make the transformation and when otherwise it is impossible to know whether the 
therapy staved off the dementia or whether the individual was never going to develop dementia in 
the first place. Several imaging techniques, diagnostic tests and clinical trials have been proposed 
to form a prognosis for transformation from PD-MCI to PDD by Melzer et al 
(18, 19, 20)
. 
1.04 Clinical Examinations Used in the Diagnosis of PD, PD-MCI and PDD 
There are several clinical examinations performed by clinicians to determine the current state of 
PD and its severity 
(14)
. Each trial involves the patient performing a series of tests that are 
individually scored by the clinician and are often combined to form an overall continuous score 
that reflects the magnitude of severity of a particular aspect, or group of aspects, of PD 
(14)
.  
These are performed to track the progression of disease somewhat quantitatively and to evaluate 





The Hoehn and Yahr scale is one measure of PD severity and is measured on a scale of 1 to 5. A 
patient score depends on specific states of physical independence and observation. 
The Unified Parkinson’s Disease Rating Score (UPDRS) is the most commonly used continuous 
scale in the clinical study of PD 
(21)
. UPDRS is split into 6 separate parts with part II and III being 
used in this study. Each part is further broken down into subscales
 (21)
. Part II is based on the 
patient’s own self-evaluation of how PD is affecting their daily lives and capabilities 
(21)
.   
Examples of subscales include grading their ability to walk, to keep from falling or turning in 
bed, to speak, to swallow and prepare their own food, get dressed, practise basic hygiene and to 
write 
(21)
. Part III is a scored evaluation by a clinician of motor function based on physical 
measurements of individual patient performance 
(21)
.     
Although UPDRS is the most commonly used scale for PD it has its limitations, including a lack 
of consistency among the scoring of subscales, the lack of reproducibility of subscales and 
primarily the small emphasis on non-motor features including cognition 
(21)
.  Criteria now exist 
for the diagnosis of PD-MCI developed by The Movement Disorder Society Task Force 
(MDSTF) specific to cognition designed to differentiate between PD-N, PD-MCI and PDD 
(14, 22)
. 
Level II MDSTF criteria is made up of five cognitive domains, attention and working memory, 
executive function, language, learning and memory, and visuospatial performance 
(14)
. Each 
domain is split into a series of tests with the results of each test given in terms of a z-score, which 
is the number of standard deviations of the result from the mean result accounting for age, 
education, and sex. PD-MCI is defined as a z score of -1.5 or 1.5 standard deviations below the 
average result in at least two tests within a single domain, PDD as having a z-score of -2 in any 
test within two domains and PD-N is defined as any patient that does not meet the criteria for PD-
MCI or PDD 
(22)
. The average z-score of all 5 domains can be used to represent the overall 
cognitive ability of the patient and is referred to as the cognitive z-score (CogZ). 
1.05 Introduction to Quantitative Susceptibility Mapping and Magnetic Susceptibility 
Quantitative susceptibility mapping (QSM) is a novel magnetic resonance imaging (MRI) post-
processing procedure. Essentially QSM solves for the magnetic susceptibility of each voxel (3D 
pixel) in a multi-slice gradient echo (GRE) scan, in this case a brain scan, to give an idea of how 
the magnetic susceptibility varies in 3D throughout the brain 
(23)
. Magnetic susceptibility, χ, is 
defined as the degree of magnetisation of a material (𝛿𝑀) subject to a unit magnetic field (𝛿𝐻) 
and is an intrinsic property of all materials 
(23)
, 






                                               (1.01) 
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Figure 1.02 a & b: The alignment of magnetic dipoles in a human a) before an external magnetic field is applied 
and b) after an external magnetic field is applied 
(27)
. 
M and H are both magnetic fields with the unit ampere per metre hence χ is dimensionless 
(23)
. 
Magnetic susceptibility varies depending on the chemical constituents of the material and their 
bonding type and can either be positive (magnetisation parallel with the external field or 
paramagnetic) or negative (magnetisation anti-parallel with the field or diamagnetic) 
(23)
. 
Therefore χ is a complex value with both magnitude and direction 
(23)
. This property of χ causes 
the observed χ value to vary depending on the shape and orientation of the object being 
investigated relative to the externally applied magnetic field 
(23)
.  
Iron is ferromagnetic and has one of the highest magnetic susceptibilities of any element, 200,000 
(SI units); even in salt solution it has a χ, 0.00075 SI units, that is roughly 2 orders of magnitude 
higher than human soft tissue, -0.000009 (SI units) 
(23, 24)
. Therefore with QSM small iron 
deposits in the BG and related structures could act as a non-invasive biomarker for PD and could 
show contrast with healthy individuals. If a correlation between QSM and PD is found in brain 
structures related to PD it may aid in the diagnosis of PD-MCI and PDD and more importantly 
the prognosis of PDD also.  
1.06 Fundamental Physics of MRI 
In order to understand the fundamentals of MRI you have to go right down to the building blocks 
of atoms. Wolfgang Pauli discovered in 1927 that subatomic particles such as protons, neutrons 
and electrons don’t actually just sit still in their respective places in an atom, they actually rotate 
(25)
. He also found that the same subatomic particles ‘pair up’ and spin in opposite directions to 
each other, effectively cancelling out each other’s ‘spin’ 
(25)
. If an element or isotope has an odd 
number of nucleons (protons and neutrons) then there will always be one un-paired nucleon 
(25)
. 
This will give the nucleus a net spin (nuclear spin) 
(25)
.  All types of MRI rely on the property of 
nuclear spin 
(26)
. Nuclear spin is 
possessed by the following 
atoms/isotopes, which are present in 
























C are the most common 
(25)
. 
Nuclear spin is the net quantized or 
discrete intrinsic angular momentum of 
the above nuclei 
(25)





have a continuous spectrum of angular momentums 
(25)
. The spinning nucleon creates a magnetic 
dipole moment that points along the axis of rotation and this is proportional to its angular 
momentum 
(25)
. Since angular momentum is quantized or fixed so is the magnitude of the 
magnetic dipole 
(25)
. The Gyromagnetic ratio, 𝛾, is equal to the ratio of the magnetic dipole to the 
angular momentum for a given element 
(25)
. 
Nuclei naturally have their dipoles facing in all different directions (fig. 1.02a) 
(26)
. When placed 
in an external magnetic field the majority of nuclei will align their magnetic dipoles parallel to 
the external field (fig. 1.02b) 
(25, 26)
. This occurs because this direction is at the lowest possible 
energy state for the nuclei and like most chemical or physical processes in nature, a spontaneous 
move towards the lowest energy state usually occurs 
(26, 27)
. This state is termed the ground state. 
Once the ground state is reached the net alignment of spins results in a weak magnetisation called 
longitudinal magnetisation, Mz, which is proportional to and in the direction of Bo, in the z-axis 
(26, 27)
. A very small number of nuclei will actually align their dipoles antiparallel to the external 
magnetic field, but will require energy to do so as this is the highest energy state 
(26, 27)
. 
Having aligned all the nuclei using a magnetic 
field, these nuclei can be excited using 
electromagnetic (EM) radiation such as a 
radiofrequency (RF) pulse, which is made up of 
an oscillating magnetic field, B1, emitted for a 
fixed period of time 
(27)
. This wave is emitted at 
an angle to the external magnetic field, Bo, and 
exerts a torque on the nuclei, consequently 
tilting the magnetisation into the transverse 
plane or x-y plane by a certain flip angle, α (fig. 1.03) 
(27)
. This torque will cause precession, 
which is a complex repeated motion caused by tilting the axis of rotation of a spinning object and 
can be observed in spinning tops 
(25)
. Precession occurs precisely at the Larmor frequency and is 
defined by, 
                                                                     𝜔𝑜 = 𝛾𝐵𝑜                                                                         (1.02) 
Where  𝜔𝑜   is the Larmor frequency (radians per second), 𝛾 is the Gyromagnetic ratio (Hertz per 
Tesla) and 𝐵𝑜  (Tesla) is equal to the external magnetic field 
(25, 26, 27)
.  The excitatory RF pulse is 
chosen to be at the Larmor frequency so as to cause a torque on the nuclei 
(26, 27)
. The α of the 
resultant torque is given by,  
Figure 1.03: Rotation of net magnetisation due to an 
RF pulse, B1, and nuclear precession about external 













                                                                      𝛼 =  𝛾𝐵1𝜏                                                 (1.03) 
where 𝛾 is the gyromagnetic ratio, B1 is the root mean square magnetisation of the excitatory 
pulse and τ is the time that the pulse is applied for 
(27)
. The reason why a RF pulse is used is 
because the gyromagnetic ratio is fixed for a given atom and there are limits to how big the static 
magnetic field can be that is produced by the main coils in an MRI scanner. The main constituent 
of living organisms that has spin is hydrogen, which has 
𝛾
2𝜋




. The highest 
magnetic field produced by a clinical MRI scanner is 7T, so the resultant Larmor frequency 
would be 42.58 x 10
6
 x 7 = 298.06 MHz. This frequency just so happens to correspond with the 
part of the EM spectrum called radio waves. It also just so happens that RF waves can pass 
through organic matter relatively easily, which is ideal if we would like to image living 
organisms using this phenomenon 
(26)
. 
Once the RF pulse ceases the nuclei will precess back toward the ground state, but since the 
nuclei have been displaced from their ground state they have gained energy 
(26, 27)
. As the nuclei 
precess back toward the ground state this energy is released in the form of EM radiation also at 
the Larmor frequency 
(26, 27)
. The transverse component of the radiation can be detected by 
receive coils as a changing flux as governed by Faraday’s law 
(28)
. The resultant EM radiation 
detected is a sum of all the individual fields from the precessing nuclei 
(28)
. This process only 
works because the nuclei were prealigned prior to excitation 
(28)
. Initially after excitation the 
nuclei all precess at the same time and consequently their magnetic fields all point in the same 
direction and add together 
(28)
. If a RF pulse is emitted without an external magnetic field applied 
there is no incentive for the now excited nuclei to change direction or energy and any EM 
radiation produced is emitted in all directions effectively cancelling out 
(28)
. 
The EM radiation detected by the receive coils can be used to construct an image, but in order to 
understand how to reconstruct an image from this signal, comprehension of the signal itself is 
required. The signal amplitude is proportional to proton density and also depends on two separate 
exponential relaxation processes, longitudinal or spin-lattice relaxation and transverse or spin-
spin relaxation with respective time constants T1 and T2 
(26)
.  
When a body is first placed in the static magnetic field, Bo, the nuclei align to give a net 
longitudinal magnetisation of magnitude Mo 
(25, 26, 27)
. If a RF pulse at the Larmor frequency is 
applied 90º relative to the external field then all of the longitudinal or z-component of the ground 
state magnetisation will be transferred to the transverse or x-y plane  (fig. 1.04) 
(26, 27)
. At the 
moment the RF pulse ceases the longitudinal magnetisation will be 0, but as the nuclei precess 
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Figure 1.05: Going from left to right you have the 
initial magnetisation, Mo, then the RF pulse is 
applied tipping this magnetisation into the 
transverse plane, followed by dephasing, which is 




towards ground state this magnetisation in the 
longitudinal direction will increase 
(26, 27)
. This is 
depicted by fig. 1.04 and the process can be 
described mathematically by the following 
equation, where t is the time elapsed after the RF 
pulse has ceased and T1 is the time taken for the 








At the moment the RF pulse ceases the transverse 
magnetisation, Mxy, will be equal to Mo and will 
decrease as the nuclei return to ground state 
(26, 27)
. It 
is often mistaken that the Mxy is being converted to 
the Mz during the return to ground state, but this is 
not the case as the two processes are independent of 
each other. The decay of the Mxy occurs faster than 
the build-up of Mz, i.e. T2 < T1 
(26, 27)
. This is due to an additional effect that reduces the Mxy 
called dephasing, which is demonstrated in fig. 1.05. 
Each proton has a unique local magnetic field that it experiences determined by its specific 
location relative to other spinning nuclei nearby, which adds or subtracts from Bo to determine its 
individual precession frequency 
(26, 27)
. Also slight variations in the static magnetic field 
depending on spatial location cause the precession frequency of protons to vary based on their 
position in the B0 field.  After an RF pulse the nuclei initially precess totally in sync or in phase, 
but as they precess towards the ground state they become gradually out of phase due to the slight 
variations in precession frequency caused by different magnetic field environments experienced 
by individual nuclei 
(26, 27)
. This loss of coherence reduces the overall magnitude of the Mxy, 
which is termed dephasing 
(26, 27)
. For a 90º pulse this dephasing does not affect Mz, as all the 
individual magnetic dipoles of nuclei always have a vertical component that is greater than or 




The Mxy does not show a simple exponential decay trend, but instead forms a simple harmonic 
motion like exponential envelope, which oscillates between positive and negative magnetisations 
Figure 1.04: The exponential build-up curve for the 
magnetisation of nuclei in the longitudinal or z 






whilst decaying (fig.1.06) 
(27)
. This is 
because precession is causing the 
magnetisation to rotate between a 
positive x-y transverse direction and a 
negative transverse x-y  
direction, changing the magnitude 




envelope of the transverse 
magnetisation is usually all that we are interested in and this can be expressed mathematically as,  




                                         (1.04) 
Note that T2 *, not T2 is used, which is the combined transverse relaxation constant,  
 









                                              (1.05) 




) as well as pure T2 non-recoverable dephasing due to inter and 
intramolecular interactions and magnetic shielding 
(30)
. T2* in equation 1.05 represents the time 
taken for the transverse magnetisation to fall to 
1
𝑒
 or 0.368 of Mo. 
As discussed earlier T1 is larger than T2, with typical values for each time constant of 800ms and 
30ms respectively 
(30)
. However T1, or T2, or sometimes both T1 and T2, have different values in 
different tissues and this is a key property when looking at imaging an organism, as it allows us 
to differentiate between, and therefore potentially see, different tissue types in an organism 
(30)
. In 
general, more dense tissues attenuate the transverse magnetisation faster, causing a reduction in 
T2 and a faster transition to ground state so often T1 is also reduced, so more dense tissues have 
lower T1 and T2 values 
(30)
. 
If you want to form a multi-dimensional image, the precessing frequency of individual nuclei 
must be made dependent on its unique spatial position 
(30)
. So far signals investigated are from 
samples placed only in a static magnetic field and are a measure of Mxy and Mz as a function of 
time with no spatial information 
(30)
. Lauterbur introduced the concept of magnetic gradients 
Figure 1.06: On the right is the damped simple harmonic motion 
(Free induction Decay or FID) of the transverse magnetisation, of 
which the amplitude decreases exponentially. The envelope of 
this oscillation indicated as the dashed line is plotted on the left 







which are additional weaker magnetic fields with varying strength along a single axis for example 
the z-axis, mathematically expressed as 
(30)
,   
 
                                                                     𝐺𝑧 =
𝜕𝐵𝑧
𝜕𝑧
                                                  (1.06)                                            
As seen in equation 1.02, protons precess at a Larmor frequency proportional to its local 
magnetic field strength and only transmit a signal when this matches the RF pulse frequency 
(25, 
26, 27)




                                                                 B(z)=Bo+z.Gz                                      (1.07)      
                                               f(z) = γ(Bo+z.Gz)                                         (1.08) 
When magnetic gradients are applied, the detected signal 
which is an echo, has an intensity which is both a function 
of time and the magnitude of the chosen gradient 
(30)
. 
Gradients can be applied along the three MRI axes, called 
slice select, readout (frequency encode) and phase encode, 
to allow unique intensity values for each spatial location 
enabling multi-dimensional imaging 
(30)
.  
Firstly, a slice of tissue of arbitrary thickness, orientation 
and position is isolated by applying a magnetic gradient, 
GS, in the slice select or z-axis, simultaneously with the RF 
pulse, as seen in fig. 1.07 
(30)
. The RF pulse applied does 
not have a single frequency, but rather a range of 
frequencies termed its bandwidth, and this determines slice 
thickness 
(30)
. This slice is then spatially encoded in the 
remaining readout (x-axis) and phase encode (y-axis) 
directions.  
The frequency encoding is described in fig. 1.08 and uses a 
second magnetic gradient, Gf, in the x-axis, which is 
applied during signal acquisition 
(30)
. The phase encoding 
gradient, GP, is applied between the RF pulse and the echo 
Figure 1.07: A linear magnetic gradient is 
applied on top of the static magnetic field 
giving each ‘slice’ of the subject its own 
unique Larmor frequency, ωc. This can be 
used to select a slice, zc by applying a RF 
pulse with a frequency equal to ωc 
(30)
.  
Figure 1.08: In the x plane of the slice selected in fig. 1.07 another magnetic gradient, Gf, is applied during 





Figure 1.09: Demonstration of phase encoding. Bp is the direction of the magnetic field due to the phase 
encode gradient Gp. The gradient causes a fixed spatially dependent phase difference between spins in the 
direction of the phase encode gradient 
(27)
. 
signal and alters the phase of the nuclei prior to sampling the echo intensity 
(30)
. Before GP 
application protons are in phase, GP however changes their precession frequencies according to 
position along the phase-encode axis, making them out of phase 
(30)
. When GP, is switched off, 
nuclei revert to the original frequency, but are now phase encoded as they keep these acquired 
phase angles (fig. 1.09) 
(30)
. Therefore by using GS, Gf and GP one can isolate an MR signal from a 
single voxel in 3D space. The various unique combinations of RF, GS, Gf and GP gradient pulses 





In order to produce an image however you require an echo. An echo can be created by inverting 
the proton spins with a 180˚ RF pulse 
(27)
. This takes the protons that have a higher Larmor 
frequency that were leading in terms of 
phase (fig. 1.10b) and causes them to lag 
(fig.1.10d), and the protons with a slower 
Larmor frequency that were previously 
lagging behind now lead in terms of phase 
(27)
. The protons with a higher Larmor 
frequency catch up to those with a lower 
Larmor frequency causing a regaining of 
Figure 1.10: An example of the basic spin echo pulse sequence accompanied by the equivalent magnetization 
vectors at key stages of the sequence. a) 90º RF excitation pulse is applied tipping Mz into the transverse plane. 
b) dephasing occurs with leading (A) and lagging (B) vectors cancelling out and reducing observed Mxy signal. c) 
180 º RF pulse inverts the spins. d) the once leading A now lags in phase, but due to its higher Larmor frequency 
it begins to catch B. e) A catches up to B or refocuses leading to an echo 
(31)
. The echo occurs at 2τ where τ is the 






Figure 1.11a & b: a) Longitudinal relaxation of materials with different T1 values after a standard 90° RF pulse. 
Suggested times, TR1 and TR2 for a possible second RF pulse that can be used to generate contrast in a T1W 
image are included 
(34)
. b) Transverse relaxation of materials with different T2 values after a standard 90° 




 a b 
phase coherence and a secondary peak in signal amplitude called an echo (fig.1.10e). This is what 
is individually measured in every voxel of an MRI image 
(27)
. The echo occurs at exactly 2τ 
where τ is the time between the excitation pulse and the 180˚ pulse, which allows predictable 
measurement of the echo signal 
(27)




Another method that can be used to generate echoes uses gradients to refocus the proton spins 
instead of a 180° RF pulse 
(27)
. Spins are dephased by a successive series of pulsed gradients in 
the phase encode axis with a gradual reduction in amplitude of each pulse before spins are 
rephased by a series of pulsed gradients with the exact opposite polarity and amplitude to 
generate the echo 
(27)
. This method of MRI imaging is called gradient echo (GRE). GRE differs 
from standard spin-echo in that it can only be weighted to T2
*
 and it allows the use of flip angles 
less than 90°, which also shortens imaging time 
(27)
. If GRE is coupled with a spoiler gradient 
which destroys residual signal left over after an echo has been read, then one can image very 
rapidly 
(27)
.  This method of imaging is called spoiled gradient echo (SPGRE) 
(27)
. 
The resultant magnitude of the signal that is produced as a result of the echo is dependent on its 
relaxation parameters T1, T2 or T2
*
, the time between excitation RF pulses or the repetition time 
(TR) and the amount of time between the excitation RF pulse and the generated echo or the echo 
time (TE) 
(27)
. By changing TE and TR parameters one can ‘weight’ the image for T1 or T2 
(27)
. 
You will see contrast in your resultant image between tissues of varying T1 or T2 depending on 
which relaxation process you applied weighting to 
(27)
. In general short TRs give little time for Mz 
to recover before the next excitation and hence tissues with a long T1 appear dark and tissues with 










Figure 1.12: Demonstration of how to make a phase image and magnitude image from raw real and imaginary 
images 
(32)
.  The phase image on the left is given as the arc tangent of the imaginary image divided by the real 
image. The magnitude image is given as the square root of the sum of squares of the real and imaginary images 
(32)




. Long TEs allow tissues with a short T2 to decay completely whilst tissues with a longer T2 
retain signal providing T2 weighting (fig. 1.11b). Different tissues in the human body have 
different spin lattice arrangements and hence different T1s therefore T1 weighted imaging is 
commonly referred to as structural imaging and is used to obtain detailed structural and 
anatomical information 
(27)
. Pure T2 imaging is used less often however T2* weighted imaging 
follows the same lines as T2 and is used in a variety of applications, from functional MRI to 
diffusion MRI 
(27)
.   
Signals are measured in receive coils via EM induction perpendicular to the B0 field and can only 
be measured in the transverse plane due to requiring Faraday’s law to be detected 
(27)
.  When 
signals are detected they are not 
detected as one, but rather a pair 
of x and y components in the 
transverse plane separated by 90 
degrees (fig. 1.12) 
(27)
.  These are 
referred to as real (x) and 
imaginary (y) components 
(27)
. 
For typical gradient echo MRI 
real and imaginary data are 
acquired for each voxel in the 
image 
(27)
. The real and 
imaginary components are then 
usually combined together to 
form either a magnitude or a 
phase image and afterward the 
raw real and imaginary 




1.07 Image Acquisition & Fundamental Physics of Quantitative Susceptibility Mapping 
SPGRE is the most commonly used sequence for QSM 
(23)
. The first major point of difference 





store the data as a real and imaginary image pair instead of a magnitude or a phase image 
(23)
. 
This is because we need to be able to generate both of these images to perform QSM 
(23)
. 
The basis of QSM actually stems from an artefact seen 
primarily in GRE imaging called the magnetic 
susceptibility artefact 
(23)
. When the main B0 magnetic field 
is applied to a person during MRI that person responds by 
becoming magnetized 
(23)
. If there is a difference in 
magnetisation between voxels, as is the case with most 
tissue interfaces or boundaries, this will produce a much 
smaller local magnetic field that alters the Larmor 
frequency and hence the phase of the precessing protons 
from what they’re expected to be, similar to the phase 
encode gradient explained in section 1.05 
(23, 27)
. The larger 
the difference in magnetic susceptibility the larger the local 
magnetic field is and the larger the frequency and phase 
shifts 
(23)
. Most tissues in the human body don’t have very 
high magnetic susceptibilities so these local fields are 
typically small enough to be ignored 
(23)
. They only become 
a problem when objects of high magnetic susceptibility, 
like metal implants for example, are in or near your image 
volume (fig. 1.13) where they can cause anatomical warping and significant loss of signal 
(23)
. 
The phase and frequency shifts are time dependent so with longer echo times you can still 
experience some small signal loss and spatial warping as a result of less significant magnetic 
susceptibility differences such as those seen in the human body 
(23)
.  Magnetic susceptibility 
differences also lead to an artefact whereby objects with higher magnetic susceptibilities appear 
larger in the image then their true size and this is called partial voluming 
(23)
. Since GRE is T2* 
weighted it is particularly sensitive to the magnetic susceptibility artefact as the most significant 
contributor of field inhomogeneities causing T2* decay are tissue boundaries and susceptibility 
differences 
(23)
.  For the above reasons longer TEs are generally avoided in standard GRE 
(23)
.   
Instead of suppressing or avoiding the magnetic susceptibility artefact, QSM actually uses it to 
obtain extra information about the tissues being imaged 
(23)
. The goal of QSM is to purposefully 
exaggerate any natural magnetic susceptibility artefacts as much as we can by imaging with GRE 
over a prolonged TE, then measure the resultant phase shifts generated by local magnetic fields 
Figure 1.13: Demonstration of the 
magnetic susceptibility artefact. 
Susceptibility artefacts of this magnitude 
are often caused by a hairclip or other 
metallic object located in the imaging 
volume. The local field generated by the 
object with high magnetic susceptibility 
is large enough to shift the Larmor 
frequency and phase so that the signal is 
accidentally taken as coming from a 
different spatial position in the image 
(anatomical warping) or large enough to 





by generating phase images and finally back calculate what the magnetic susceptibilities would 














The first step toward QSM is working out the phase shift due to susceptibility differences, which 
is simply the difference between two successive phase images of the same slice. Since there are 
relatively small differences in magnetic susceptibility you have to image over a fairly long time 
to establish these small differences in susceptibility as detectable and distinct phase shifts 
(23)
.  
The problem is as you image over a longer period of time the overall signal that the phase is 
extract from decays exponentially and eventually all that is left is noise (fig. 1.14) 
(27)
.  So instead 
of taking one image at say 3ms and another at 30ms, you take multiple images between 0ms and 
30ms at regular time intervals and use them to get a better idea of what the total phase shift is 
without being significantly impacted by noise
 (35)
. This method also improves the overall signal to 
noise ratio of the magnitude image used later in processing 
(35)
. In order to perform this you need 
a very fast imaging sequence and hence SPGRE is the ideal sequence for QSM.  
Ideally the observed phase shift (φ) is equal to the local change in magnetic field (δB) due to 
susceptibility divided by the gyromagnetic ratio (γ) multiplied by the echo time (TE)
 (36)
.  
                                                   𝜑 = − 
𝛿𝐵
𝛾𝑇𝐸
                                                 (1.09) 
TE = 3.5ms TE = 7.3ms TE = 11.1ms TE = 14.9ms 
TE = 18.7ms TE = 22.5ms TE = 26.3ms TE = 30.1ms 
Figure 1.14: A series of 8 phase images taken with SPGRE at different echo times (TEs) ranging from 3.5 to 
30.1ms. As time goes by the noise in the phase images gradually increases. Images obtained from the New 
Zealand Brain Research institute (NZBRI). 
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 to yield the local magnetic field in each voxel, but unfortunately this formula does not 
hold due to the noise in the phase images. A better approach solves a nonlinear least squares 
problem in each voxel to account for the growing noise in each subsequent image 
(35)
.  Besides 
the non-linear model the curve is also weighted such that the first calculated phase shift, which 
has the least noise, has the highest weighting and the last phase shift has the lowest 
(35)
. 
             𝛿𝐵 = 𝑎𝑟𝑔𝑚𝑖𝑛 ∑ |𝑆(𝑟, 𝑇𝐸𝑗) −  𝐴(𝑟, 𝑇𝐸𝑗)𝑒
−𝑖𝜙(𝑟)𝜔0𝑇𝐸𝑗|
2𝑁𝑒
𝑗=1            (1.10) 
Where 𝑆(𝑟, 𝑇𝐸𝑗) is the total measured complex amplitude of the MRI signal (phase + magnitude) 
at position 𝑟 in the image at the jth TE and 𝐴(𝑟, 𝑇𝐸𝑗) is the modelled signal represented as a 
complex amplitude multiplied by a phase, 𝜙, linear in time at the same 𝑟 and 𝑇𝐸 with angular 
velocity 𝜔0 equal to the Larmor frequency (Eq. 1.02) 
(35)
. After complex TE curve fitting of the 
raw image data to determine the local field, 𝛿𝐵, it is possible for total phase shifts to occur that 
are greater than 2π causing these voxels to appear as if they haven’t undergone any phase shift at 
all. Phase unwrapping is a process that corrects the local field for this effect by checking that the 
phase in the image is spatially continuous 
(35)
. 
The difficulty in working out QSM is that the local magnetic field in any given voxel of the 
image isn’t solely produced by the magnetic susceptibility differences between that voxel and its 
neighbouring voxels, it’s also theoretically affected by every other surrounding voxel as well not 
just in 2D, but in 3D, all of which can have different unknown magnetic susceptibilities 
(36)
. Each 
voxel effectively acts as an individual magnetic source with its strength directly proportional to χ 
and from the total combined field of these susceptibility sources we somehow have to determine 
each individual source’s strength 
(36)
, 
                                               𝛿𝐵 = 𝐵0(𝑋 ⊗ 𝑑(𝑟))                                      (1.11) 
Where X is the magnetic susceptibility distribution of your image and d(r) is the magnetic dipole 
kernel given by the following expression 
(36)
, 
                                                 𝑑(𝑟) =  
3 cos2(𝜃)−1
4𝜋𝑟
                                         (1.12) 
Where (𝜃) is the angle between the direction of B0 and 𝑑(𝑟) 
(36)
. 
This problem can be solved using spherical deconvolution and the problem is made much simpler 
due to the fact that the local fields produced within the human body are small and often only act 
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over distances of no more than 5mm, which is what is used as the radius of the spherical kernel 
(36)
.  
The problem is however that there isn’t just one, but in fact many different magnetic 
susceptibility distributions that can give rise to the exact same observed local magnetic field map, 
also known as an ill-posed problem 
(36)
. There isn’t actually enough information to narrow down 
the possibilities to a definitive answer. This is complicated further by noise in the phase images 
that derived the local field so one cannot be exactly sure what the actual local magnetic field 
really is 
(35)
.  So in order to quantify magnetic susceptibility in each voxel we have to pick one 
solution out of countless different possibilities that actually represents the true underlying tissue 
properties that we’re interested in 
(36)
. There are a few different ways to do this and there is still a 
bit of debate over which method is the best, however non-linear morphology based dipole 
inversion (MEDI) appears to have the best accuracy and reproducibility 
(35, 37)
.  
MEDI uses a magnitude image from the raw real and imaginary data as an ‘a priori’ to find out as 
much as possible about the nature of the true χ distribution in order to make an informed decision 
on which solution to choose 
(36)
.  There are two specific pieces of information in the magnitude 
image that can be used. The first is the edges 
(36)
. The edges give us a good idea of where the 
tissue boundaries or interfaces are in the image 
(36)
. These are the areas that are most likely to 
experience the largest difference in magnetic susceptibility and the edges can be found within the 
magnitude image automatically using an edge filter 
(36)
. The second piece of information that can 
be used is which areas are homogenous 
(36)
. These are the areas that are most likely to have the 
same magnetic susceptibility 
(36)
. The homogenous areas of an image can be obtained by 
subtracting the edge filtered image from the original magnitude image 
(36)
. These two pieces of 
information are used to construct two separate matrices, each containing weightings representing 
the likelihood of any given voxel having a different magnetic susceptibility from its neighbours 
or the same magnetic susceptibility as its neighbour 
(36)
. Then Bayesian regularization is 
performed minimizing the sum of squared differences between the local field generated by the 
proposed X and that of the local field distribution (𝛿), with these two matrices acting as 
additional constraints. The full minimization problem is given below: 
                                      𝑚𝑖𝑛𝑋‖𝑊(𝐶𝑋 − 𝛿)‖2
2 +  𝛼2‖𝑊0𝑋‖2
2 +  𝛽2‖𝑊1𝑋𝐺‖2
2            (1.12)                                                         
Where X is the magnetic susceptibility distribution, δ is the local magnetic field map, C is the 
convolution kernel matrix, α and β are regularization terms, W is a matrix containing weightings 
for the noise in δ, W0 and W1 are the homogeneity and edge matrices containing the weightings 
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Figure 1.15a & 1.15b: a) a QSM reconstruction of the brain without background field removal (BFR) and b) a QSM 
reconstruction with Laplacian boundary value (LBV) BFR demonstrating the impact of the residual field generated 
by the skull. As can be seen in figure 1.14a artificial signal has drifted into the anterior and posterior regions of 
the brain 
(Liu2013)
. Images obtained from the New Zealand Brain Research institute (NZBRI). The window and level 
of both images is 0.5 & -0.25 respectively. 
for homogenous regions and edges respectively and G is a matrix containing the gradient operator 
along each axis of the image 
(36)
.  
However the process described above has one major oversight and that is that you assume there is 
only small magnetic susceptibility differences and therefore only local fields present that act over 
small distances 
(35)
. There is one tissue in the human body that does have a significantly higher 
susceptibility then most others and that tissue is bone, specifically the calcium in bone, and when 
the magnetic susceptibility artefact is purposefully exaggerated the skull to air and skull to dura 
interfaces produce a magnetic field large enough to actually cross over into the brain 
(35)
. QSM 
can’t be performed in the brain with this background field present so what needs to be done is not 
just determine the local field within the brain, but also determine the field generated outside the 
brain by the skull and air interfaces as well, using Maxwell’s equations 
(35)
. Then the background 




Because there are tissues in the body that are diamagnetic and paramagnetic, both positive and 




a) b) a) 
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Figure 1.16a-d: Exemplar QSM images and comparison with structural T1-weighted images. Figure 1.16a 
demonstrates two of the most prominent structures visible in QSM; the substantia nigra (green) and the red 
nucleus (red). These structures are near invisible in the structural T1-weighted image (Figure 1.16b). Figure 
1.16c & d demonstrate the globus pallidus (orange) and putamen (purple) collectively called the striatum, the 
caudate nucleus (blue) and the thalamus (yellow). QSM is capable of accurately depicting the medullary 
lamina that separates the internal and external segments of the globus pallidus as indicated by the black 
arrow. Note that the QSM BG structures appear larger than the true anatomical size of the structural T1-
weighted image demonstrating the extent of partial voluming. The QSM images have a window and level of 
0.5 and -0.25 and the structural images have a window and level of 10,000 and 500. Images obtained from 






















QSM produces the highest known contrast and signal to noise ratio out of any other MRI 
sequence or virtually any other non-invasive imaging modality for that matter for several key 
grey matter structures in the brain 
(36)





nuclei (RN), which are near invisible in structural T1-weighted images, however in QSM they 
show up very clearly (fig. 1.16a) due to their naturally higher iron content. Another prominent 
example is the striatum in which you can clearly differentiate between the GP and the putamen 
(fig. 1.16c) and sometimes even between the internal and external segments of the GP. The 
caudate and thalamus are also often distinguishable. 
1.08 Previous Studies on PD using QSM 
Recent studies by Langkammer, Schweser and Zheng et al have estimated iron deposition in the 
brain non-invasively using QSM 
(38)
. Barbosa, Guan, He and Du et al then correlated iron 
deposition in the SNc, estimated with QSM, to PD, however these studies did not investigate the 
links between iron accumulation in BG structures and cognitive impairment in PD or the 
development of dementia 
(38, 39, 40, 41)
. Du et al also found that QSM in the SNc correlated with the 
duration of disease, with UPDRS II scores & Levodopa equivalent daily dosage. Guan et al noted 
patients with ‘late PD’ (Hoehn & Yahr >3), had additional increases in QSM in the SNr, GP 
(especially internal GP) and RN compared to early PD (Hoehn & Yahr<2.5) and HCs. Iron is 
used in neural metabolism throughout the brain not just in the SNc and other dopaminergic sites, 
hence it is possible that iron accumulation could occur in other nuclei associated with the SNc 
such as the SNr and GP as a result of PD 
(42)
.  The Hoehn & Yahr scale is primarily gauged on 
motor symptoms, which are primarily the cause of SNc degeneration, with the SNr and GP being 
involved in some cognitive 
(14)
. It’s possible that the increases in QSM Guan et al found in the 
SNr and GP interna weren’t related to Hoehn & Yahr at all, but in fact were related to underlying 
cognitive decline, which is coincidentally more common in later stages of PD 
(16)
. Guan however 
did not investigate whether these increases in QSM outside of the SNc were related to cognition. 
Acosta-Cabronero et al. performed the first whole brain QSM analysis in late 2016 noting no 
global differences in QSM for striatum or primary motor and somatosensory cortices, but 
differences in parts of temporal, paralimbic, occipto-parietal & prefrontal cortices as well as the 
rostral pontine area 
(42)
. 
1.09 Project Aim 
The first goal of this study was to demonstrate increased QSM values in the SNc in PD relative to 
controls. The second goal and primary aim of this study was to determine whether increased 
QSM in the SN and associated nuclei is correlated with cognitive impairment in PD. A final aim 
was to perform a whole brain QSM analysis, as opposed to single grey matter structures, to test 




Chapter 2: Method 
2.1 Subjects, Clinical Assessment & Image Acquisition 
A convenience sample of 114  participants meeting the UK Parkinson’s Disease Society’s criteria 
for idiopathic PD was recruited from the Movement Disorders Clinic at the Van der Veer 
Institute for Parkinson’s and Brain Research, Christchurch, New Zealand. Volunteers 
representative of the broad spectrum of cognitive status in PD were invited to participate. The 
control group comprised of 30 healthy volunteers matched to the whole PD sample for mean age, 
years of education and sex ratio. Exclusion criteria included atypical parkinsonian disorder or 
other CNS disorder; previous history of other neurological conditions including moderate or 
severe head injury, stroke, learning disability or vascular dementia; and major medical illness in 
the previous 6 months. 15 subjects were excluded due to having insufficient or no clinical data. 6 
more were excluded due to excessive motion artefacts (visually assessed) as motion arteficially 
induces phase shifts, leading to unreliable QSM values. 1 subject was excluded due to incorrect 
scanning parameters, and later 2 others due to processing errors. Analyses were conducted on the 
remaining 97 PD and 24 control subjects. This sample provides a reasonable representation of the 
local community of PD patients, including the full spectrum of cognitive impairments, as our 
Movement Disorders Clinic assesses the majority of patients in the region. All subjects gave 
written consent, with additional consent from a significant other when appropriate. The Upper 
South Regional Ethics Committee of the New Zealand Ministry of Health approved the study. 
Disease severity was assessed using the Unified Parkinson’s Disease Rating Scale (UPDRS: part 
III, motor). Comprehensive neuropsychological testing classified PD patients as either 
cognitively normal (PD-N; n=31), with mild cognitive impairment (PD-MCI; n=56) or with 
dementia (PD-D; n=10), using level II clinical criteria established by the Movement Disorders 
Society (MDS) Task Force as outlined by Wood et al. 
(22)
. Dementia diagnosis was also based on 
the MDS Task Force criteria. PD-MCI cases had unimpaired functional activities of daily living, 
but scored 1.5 SDs or more below normative data on at least two measures within at least one of 
the four MDS Task Force cognitive domains (executive function; memory; attention, working 
memory and speed of processing; and visuospatial/visuoperceptual function). 
The mean age for the entire study population was 72 years with a standard deviation of 7 years.  
Table 1 below summarizes the sex distribution across the different categories. The categories 




Sex Healthy Control PD-N PD-MCI PDD Total 
Female 6 11 16 0 33 
Male 18 20 40 10 88 
Table 2.1: Sex distribution of the population. The ratio between male and female is 8:3, which is normal, PD is 
more common in males than females. There was roughly an even distribution of sex in each category except PDD 
due to limited availability. 
Image Acquisition: Real and imaginary image pairs were acquired for 8 different and evenly 
spaced TEs between 3.8ms and 32.1ms  (3.8ms TE spacing) using a spoiled gradient recalled 
echo (SPGR) sequence with TR=42.8ms, flip angle=20° and a bandwidth of 244.141Hz. This was 
repeated for 60 transverse slices (2mm thickness) per subject covering the total volume of the 
brain. The QSM image matrix was 512x512 with a FOV=240mm resulting in 0.47mm  x 0.47mm  
x 2mm voxels. Total scan time was ~5 minutes. Structural T1-weighted images, with a TR= 
6.6ms, TE=2.8ms, α=15°, a bandwidth of 122.07Hz an image matrix of 256 x 256 and voxel size 
0.98mm x 0.98mm x 1mm (170 slices, total imaging time=5:09) have also been acquired 
separately for the purpose of caudate, GP, putamen and thalamus segmentation as structural T1-
weighted imaging has the highest resolution and contrast for these nuclei. All imaging was 
performed using a GE Healthcare Signa HDxt 3T MRI scanner at Hagley Radiology.  
2.2 Pre-processing 
Initially a check was done to ensure that the duration between each TE of each image for a given 
slice, or the TE spacing, in all subjects was held constant as the QSM code requires this to be 
constant and will otherwise interpolate phase to constant TE across all images introducing 
additional error 
(35)
. The duration between each TE was found to be constant within all subjects 
with only two subjects showing a minor variation (3.812 & 3.848) in TE spacing compared to the 
other 110 subjects (3.808ms). All subjects also had minor variation in the first TE (±0.05ms). The 
overall standard deviation in each of the 8 TEs between subjects was found to be no more than 
±0.06ms.  
All the acquired images were converted from the DICOM format that they were initially obtained 
with to NIfTI using statistical parametric mapping (SPM) 12 software. NIfTI is a file format that 
allows us to perform several key steps in data processing and analysis such as coregistration and 
normalisation with SPM 12 and linear regression analysis with FSL, and is also part of the 
current convention for neuroimaging. Down sampling was performed on the structural T1-
weighted images due to the DICOM to NIfTI conversion producing unnecessary and excess 
interpolation also with SPM12.  
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2.3 QSM Testing & Reconstruction 
In order to produce the quantitative susceptibility maps (QSMs) we used a MATLAB code 
provided by T. Liu et al (University of Cornell) 
(35)
. The code produced QSMs using the 
following procedure 
(35, 36, 43, 44, 45): 
1. Importing the raw real and imaginary image data as a 4D file with echo time as the 4th 
dimension. 
2. Generating magnitude images calculated as the following, 
                            𝑀𝑎𝑔 = √
𝑥12+𝑦12+ 𝑥22+ 𝑦22+ 𝑥32+ 𝑦32+⋯ 𝑥82+ 𝑦82 
8
                          (2.1) 
 Where xn and yn represent the real and imaginary images. 
3. Complex TE curve fitting of the raw SPGRE image data to estimate the local magnetic field 
4. Region growth spatial phase unwrapping.  
5. Background field removal (BFR) using either projection onto dipole fields (PDF) or 
Laplacian boundary value (LBV) methods. 
6. Reconstruction of quantitative susceptibility maps using non-linear morphology enabled 
dipole inversion (MEDI) with a kernel radius of 5mm, regularization parameter, λ, of 1000, 
an edge parameter of 0.9 and a threshold of 0.1 with units of parts per million (ppm). 
Prior to generating QS maps for the entire population, the non-linear MEDI QSM code was first 
tested to ensure that it was correctly producing QS maps. Firstly exemplar data provided with the 
code was successfully reconstructed. After fixing several issues with data importation and 
altering the code to use NIfTI instead of DICOM images, our own images were successfully 
reconstructed with the default BFR, projection onto dipole fields (PDF).  It was then discovered 
that the inbuilt threshold based brain masking program was substandard and was erroneously 
including the eyes in the brain mask (fig.2.01a), which in turn introduced background field 
artefacts (fig. 2.01c). This default masking program was replaced with the FMRIB Software 
Library’s (FSL’s) brain extraction tool (BET) with fractional intensity thresholds (f) and vertical 
gradients in fractional intensity thresholds (g) that were tailored to each individual for the best 
possible brain masks (fig. 2.01b). 
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Figure 2.01a-d: Comparison of inbuilt 
threshold based masking (fig. 2.01a) to 
FSL BET masking (fig. 2.01b). a) and b) are 
magnitude images of the same slice with 
the masks overlaid onto them in red. c) 
and d) are the resultant QS maps 
reconstructed with PDF BFR. As you can 
see in fig.2.01a the eyes have been 
included in the threshold based mask and 
as a result the reconstructed QS map in 
fig. 2.01c contains unremoved residual 
background field. FSL BET masking shown 
in fig. 2.01b is much more accurate than 
the threshold based method and hence 
the reconstructed QS map with FSL BET, 
fig. 2.01d, does not contain the 
background field artefact from the eyes. 
The QSM images have a window and 
level of 0.5 and -0.25. Images were 
obtained from the New Zealand Brain 
Research institute (NZBRI). 
Having successfully reconstructed 
QSM with the new masking, the 
different methods of BFR, PDF and 
solving a Laplacian boundary value 
(LBV) were tested. PDF was found to contain a background artefact, which was greatly reduced 
by LBV. Also 6 subjects with PDF BFR failed to reconstruct. Based on these observations and 
research conducted by Santin et al. who found that non-linear MEDI QSM with LBV BFR was 
the most reproducible QSM reconstruction and Liu et al. who found that LBV was the most 
accurate BFR for non-linear MEDI, LBV was selected as the BFR method for all subsequent 
QSM reconstructions 
(35, 37)
. Some additional changes were made to the QSM code including; 
better naming conventions for files and folders, adding the study ID obtained from DICOM tags 
to the produced QS map file names and backup files along with the method of BFR and masking 
to avoid potentially mixing these up, adding extra information to backup files to enable easy 
modification and testing of the various QSM parameters and settings and finally preparing the 
code for batch processing. High quality QS maps were then generated for all 121 subjects.  
2.4 Coregistration & Automatic Segmentation of Caudate, GP, Putamen & Thalamus  
The structural T1-weighted images were segmented using FSL's FIRST automated segmentation. 
This procedure robustly and accurately identified the caudate, putamen, globus pallidus and 





Because the structural T1-weighted images and QSM images were acquired separately, there is a 
high potential for spatial mismatch between the two (e.g., because the subject moved) so the two 
images needed to be coregistered. This was performed using SPM12 by coregistering the 
magnitude image from QSM processing, which provides better contrast and more accurate 
anatomical detail than QSM for the purposes of coregistration, to the SPGR structural images. 
The changes to the header information that defined the position and orientation of the magnitude 
images can then be applied directly to the QSM images, which had the exact same spatial 
location and orientation as the uncoregistered magnitude images. The SPM12 coregistration 
accounts for both translation and rotation. 
After coregistration the automatically segmented caudate, GP, putamen and thalamus masks 
(256x 256 x 170) were resliced with nearest neighbour interpolation using SPM12 to have the 
same resolution and number of slices as the QSM images (512 x 512 x 60). One can then apply 
those masks directly to QSM and extract the mean, median and standard deviation automatically 
for these structures. Because PD can be asymmetrical in its early stages the left and right 
structures were kept separate and were analysed individually 
(41)
. 
2.5 SN & RN Masking  
As was mentioned at the end of section 1.07, the SN and RN are almost invisible in structural T1-
weighted scans so one cannot automatically segment it using FSL FIRST. A different approach 
needs to be taken to segment these nuclei. The method used in this study followed a semi-
automated process developed by Acosta-Cabronero et al. 
(42)
. Firstly all the structural T1-weighted 
scans were segmented again and DARTEL normalized using CAT12 and the deformation fields 
produced by the segmentation were used to normalise the structural images to Montreal 
Figure 2.02a-d: SN masks (yellow) and RN masks (red) overlaid onto a HC QSM template normalised to MNI-152 
space. a) Represents the coronal view, b) and d) the sagittal and c) the transverse view. The SN can be clearly 
made out on this QSM template. QSM images have a window and level of 0.5 and -0.25. Images were obtained 







Figure 2.03a-d: Separation of the SN into SNr (green) and SNc (blue) using the IXI555 template.  In Fig 2.03c you 
can make out a dark hypointense band on the outside that is the SNr indicated by a green arrow, a lighter more 
hyperintense band on the inside that is the SNc indicated by a blue arrow. By overlaying the masks produced in 
fig 2.02 onto the IXI555 template in FSLView and increasing their transparency we were able to identify the SNr, 
which was then subtracted from the whole SN mask in fig. 2.02 to obtain the SNc. Template images have a 
window and level of 0.4 and 1.4. Images were obtained from the New Zealand Brain Research institute (NZBRI). 
 
Neurological Institute 152 (MNI-152) space using SPM12 and 5
th
 degree B-spline interpolation. 
Normalisation involves warped registration of each patient’s images to a template, In this case the 
MNI-152 template, which represents the average image, generated from a large data set. 
Normalisation removes the individual’s shape and size dependency and allows one to directly 
compare values between subjects in each voxel. Since the QSM and structural images are 
coregistered the deformation fields generated from CAT12 segmentation can also be applied to 
the QSM images. A QSM control template was formed by obtaining the average voxel wise QSM 
value from the normalised QS maps of the 24 HCs. This template was then used to mask the SN 
and RN, which could be clearly seen (fig. 2.02a-d) using FSLView. 
Although you can’t see the SNc or SNr in individual T1 weighted scans it is actually possible to 
see the SN and distinguish the two segments in some T1 templates. The QSM control template 
SN masks were then overlaid onto another T1 template, IXI555, which has some contrast between 
the SNc and SNr. In Fig 2.03c you can just make out a dark hypointense band on the outside that 
is the SNr (green arrow), and a lighter more hyperintense band between the hypointense region 
and the RN that is the SNc (blue arrow). By increasing the transparency of the masks in FSLView 
this and the RN that is the SNc. By increasing the transparency of the masks in FSLView this 
template was used to create a second mask of the SNr (fig. 2.03a-c). By subtracting the SNr mask 
from the whole SN mask one can obtain the SNc and hence separate the two portions of the SN 







Figure 2.04a-c: An example of inverse warped RN (red), SNc (blue) and SNr (green) masks overlaid onto native 
QSM in the a) coronal view, b) sagittal view and c) axial view. d) is given as a reference for c) . As can be seen in 
figures 2.04a-c the masks do not exactly match the equivalent bright areas in native QSM. QSM images have a 
window and level of 0.5 and -0.25. Images were obtained from the New Zealand Brain Research institute 
(NZBRI). 
 
SNr and RN masks we obtained individual masks for each of these structures in native subject 
space. This was performed using SPM12 with nearest neighbour interpolation. These masks were 






As can be seen in fig. 2.04a-c the individual subject SN and RN masks were not perfectly 
aligned, however time restrictions meant this semi-automated method was the most viable option.  
2.6 Bayesian Regression Modelling 
QSM values were compared across group using Bayesian multi-level regression models with the 
brms (https://github.com/paul-buerkner/brms) package in R (v3.3.1). Varying intercepts were 
included per subject, modelling their QSM values in each scan and for each ROI. Subject-level 
predictors were group (control & PD) and sex; the session-level predictor was age; all predictors 
were estimated for each ROI. The priors for the predictors were Student-t distributions of degree 
3, mean 0, standard deviation 1; similarly priors for the standard deviations were Student-t 
distributions of degree 4, mean 0, standard deviation 2. An additional model was fit including a 
session-level predictor of global CogZ to determine the association with cognition and QSM by 





This modelling technique has been successfully applied in humans in a 
longitudinal MRI study of cognitive decline in Parkinson’s disease 
(47)
. 
The first model was set up to test for the differences between PD as a whole group versus HCs 





Secondly we tested for any association between the four different categories, HCs, PD-N, PD-
MCI and PDD, for each region with sex and age as covariates, accounting for any group 
differences discovered in the prior analysis. This will be the first time anyone has attempted this. 
Additional analyses include testing for a correlation between QSM, global cognitive score 
(CogZ) UPDRS II, UPDRS III, and disease duration. The categories are derived from CogZ, but 
are also defined by the ability of the subject to perform daily tasks in living. 
The QSM values given to the model were scaled up by a factor of 100 in order to delineate 
between borderline significant trends on the order of 0.01ppm. The estimates reported were 
divided by 100 and set to 3DP. 
2.7 Whole Brain Analysis 
With the normalised QSM images produced in section 2.5 it is possible to analyse QSM on a 
voxel by voxel basis and look for potential correlations between QSM and PD throughout the 
entire brain rather than on a structure by structure basis. This may give insight into the pathology 




The first step toward a whole brain analysis is obtaining a whole brain mask. This was achieved 
by simply obtaining each individual’s white matter and gray matter masks produced by the 
CAT12 segmentation in section 2.5 and adding them together. These whole brain masks were 
then warped into MNI-152 normalised space using SPM12 and a 5
th
 degree B-spline 
interpolation. The normalised brain masks were binarized with a threshold of 0.5 and applied to 
the normalised QSM to remove cerebrospinal fluid and other non-neural tissues. Spatial 
smoothing is necessary prior to the whole brain analysis to smooth out residual coregistration 
errors and misalignments and to reduce the overall number of independent statistical tests. The 
normalised QSM and the normalised brain masks were then smoothed using SPM12 with a 3D 
Gaussian kernel of full width half maximum (FWHM) determined by the following equation 
(48)
,  
FWHM = σ√8 ln (2) ≈ σ ∗  2.35  
Where σ  is the standard deviation in mm of the Gaussian kernel. Betts et al determined that a σ  
of 3mm was optimal for a QSM whole brain analysis giving a FWHM of 7mm 
(48)
. The smoothed 
normalised QSM was then divided element wise by the smoothed mask to compensate for 





All voxel-wise comparisons implemented a general linear model, which are fundamentally 
different from the Bayesian ROI models. We tested whether PD showed increased QSM relative 
to controls using a t-test, implemented using ’randomise’, a permutation based inference tool for 
non-parametric thresholding in FSL. For each contrast, the null distribution was generated over 
10000 permutations at alpha level <0.05, correcting for multiple comparisons using threshold-
free cluster enhancement 
(49)
. Linear regression was employed to investigate the association 
between CogZ and voxel wise QSM with age, sex, and group (PD/Control) as covariates. The 
results of this linear regression were used to identify whether any significant correlations with 
cognition exist for QSM.  
The first linear regression model was made up of two contrasts testing the null hypothesis that 
QSM values are not different between PD and HCs with age and sex as covariates. The fist 
contrast was PD > HC 
𝑌 =  𝛽𝑃𝐷 −   𝛽𝐻𝐶 +   0𝛽𝑠𝑒𝑥 + 0 𝛽𝑎𝑔𝑒 
And the second, PD < HC, 
𝑌 =   𝛽𝐻𝐶  − 𝛽𝑃𝐷 +   0𝛽𝑠𝑒𝑥 + 0 𝛽𝑎𝑔𝑒 
The second linear regression model was made up of two contrasts testing the null hypothesis that 
there is no association between cognition and QSM with age, sex, and group as covariates. The 
first contrast tested whether a positive association exists: 
𝑌 =   𝛽𝑐𝑜𝑔  +   0𝛽𝑠𝑒𝑥 + 0 𝛽𝑎𝑔𝑒 + 0 𝛽𝑔𝑟𝑜𝑢𝑝 
And the second whether a negative association exists, 
𝑌 =  − 𝛽𝑐𝑜𝑔  +   0𝛽𝑠𝑒𝑥 + 0 𝛽𝑎𝑔𝑒 + 0 𝛽𝑔𝑟𝑜𝑢𝑝 
Chapter 3: Results 
Results from the Bayesian regression models will be reported first. Reported results will include 
the estimate of the effect, and its associated error. If the 95% confidence interval of the estimate 
does not cross zero, than the estimate is considered statistically significant in the classical sense 




Table 3.01: Summary of results from the group model for sex and mean QSM. All values are expressed in 
ppm (parts per million) with female as the reference for the model. The left caudate and right RN had 95% 
confidence intervals that did not cross 0, implying statistically significant reductions in QSM in males 
compared to females in these nuclei. 
 
3.1 Age and Sex Dependence 
First, age and sex effects are reported from the following model (table 3.01 and figure 3.01): 
qsm_model <- brm(QSM_dm_su100 ~ Region:age_s100 + Region:sex + Region + group:Region + 
(1|nzbri_id), 
           control = list(adapt_delta = 0.99), 
     prior = c(set_prior("student_t(4,0,2)", class = "sd"), 
                     set_prior("student_t(4,0,2)", class = "sigma"), 
                     set_prior("student_t(3,0,1)", class = "b")), 
           data=w, algorithm = c("sampling")) 
summary(qsm_model, waic = TRUE),  
Where Region:age_s100 models the region by age interaction; Region:sex, the region by sex 
interaction; and group:Region, the group by region interaction.  









Intercept                   0.005 0.005 -0.005 0.015 
Left caudate -0.012 0.005 -0.023 -0.002 
Left GP -0.005 0.006 -0.017 0.006 
Left putamen -0.007 0.006 -0.018 0.004 
Left RN -0.008 0.006 -0.020 0.003 
Left SNc 0.004 0.005 -0.007 0.014 
Left SNr    0.000 0.005 -0.011 0.011 
Left thalamus 0.005 0.006 -0.006 0.016 
Right caudate -0.003 0.005 -0.013 0.007 
Right GP          -0.001 0.005 -0.011 0.010 
Right putamen  -0.001 0.005 -0.012 0.009 
Right RN -0.012 0.006 -0.025 -0.001 
Right SNc -0.003 0.005 -0.014 0.007 
Right SNr -0.001 0.005 -0.012 0.010 




There was a small, but borderline significant reduction in mean QSM of the left caudate, and 




Figure 3.01: Boxplots of mean QSM in each region for males (M) and females (F). Males appear to have lower 
QSM than females in the left caudate, and right RN.  
Table 3.02: The relationship between mean QSM and age in each region. The left and right putamen produced 
large increases in QSM with increasing age, but these were found to be not significant. 
 
 









Intercept                   0.005 0.005 -0.005 0.015 
Left caudate 0.004 0.014 -0.021 0.035 
Left GP 0.007 0.016 -0.018 0.047 
Left putamen 0.050 0.049 -0.006 0.162 
Left RN -0.010 0.018 -0.059 0.014 
Left SNc -0.001 0.013 -0.030 0.027 
Left SNr    -0.001 0.013 -0.029 0.025 
Left thalamus 0.000 0.013 -0.026 0.025 
Right caudate -0.004 0.014 -0.037 0.021 
Right GP          0.001 0.012 -0.024 0.027 
Right putamen  0.018 0.027 -0.013 0.091 
Right RN -0.054 0.051 -0.169 0.006 
Right SNc -0.003 0.014 -0.034 0.023 
Right SNr -0.002 0.013 -0.030 0.024 




Figure 3.03a & b: Violin plots of the left (a) and right (b) SNc demonstrating the increased mean QSM for PD 












Despite seeing a notable age related increase in QSM in the left and right putamen (fig. 3.02a&b), 
this was found to be not significant in the model’s analysis (table 3.02).  
3.2 Group Analysis 
The first major comparison was the group comparison, PD as a whole vs. HCs, from the model in 
3.1. We saw a significant increase in QSM in the left and right SNc (fig. 3.03, 3.04 & table 3.03). 
While QSM was significantly increased in PD, notice the substantial overlap in fig. 3.03 a & b 















Figure 3.02a & b: Plots of mean QSM with age in the left (a) and right (b) putamen, with a linear regression fit 
demonstrating a linear increase in QSM with age in these two structures. The grey area indicates 2 standard 
deviations. The various categories are included with colour coding to provide extra information however there 





Table 3.03: Summary of results from the group analysis. A statistically significant increase in mean QSM was 











Intercept                   0.005 0.005 -0.005 0.015 
Left caudate 
-0.004 0.005 -0.015 0.006 
Left GP 
0.001 0.006 -0.011 0.013 
Left putamen 
-0.007 0.006 -0.019 0.004 
Left RN 
-0.001 0.006 -0.012 0.011 
Left SNc 
0.020 0.007 0.007 0.034 
Left SNr    
0.009 0.006 -0.002 0.022 
Left thalamus 
-0.006 0.006 -0.018 0.006 
Right caudate 
-0.008 0.006 -0.021 0.003 
Right GP          
0.003 0.006 -0.008 0.015 
Right putamen  
-0.006 0.006 -0.018 0.004 
Right RN 
-0.003 0.006 -0.015 0.009 
Right SNc 
0.018 0.007 0.005 0.031 
Right SNr 
0.004 0.006 -0.007 0.016 
Right thalamus 



















Figure 3.04: Boxplots of mean QSM for PD and controls in each region.  PD showed a statistically significant   




Table 3.04: Summary of results from the group analysis. A statistically significant increase in mean QSM was only 
observed in the left SNc for PD-N compared to HCs. Note for the right SNc in PD-N the lower bound for the 
confidence interval is -0. This is because when the results were scaled up this value was found to be slightly less 
than zero, however when scaled back to the original units this value was rounded to zero. The negative indicates 
that this confidence interval has in fact crossed zero. For the sake of simplicity just the SNc is displayed in table 
3.04. All the data from the category model is available in table A1, in Appendix A. 
 
3.3 Category Analysis 
Next the different cognitive categories were modelled using the following,  
w_nan <- subset(w,!is.na(w$category)) 
w_nan <- subset(w,w$category!="Control-MCI") 
qsm_model_cog <- brm(QSM_dm_su100 ~ Region:age_s100 + Region:sex + Region + 
category:Region + (1|nzbri_id), 
           control = list(adapt_delta = 0.99), 
           prior = c(set_prior("student_t(4,0,2)", class = "sd"), 
                     set_prior("student_t(4,0,2)", class = "sigma"), 
                     set_prior("student_t(3,0,1)", class = "b")), 
           data=w_nan, algorithm = c("sampling")) 
summary(qsm_model_cog, waic = TRUE), 
Where category:Region models the interactions between cognitive categories in PD and HCs. 
Fig. 3.05 displays the raw data by category. There doesn’t seem to be any significant trends 
between categories outside of PD as a whole and controls in the SNc. From the model we see an 
increase in left SNc mean QSM in PD-N compared to HCs, but not in the right SNc and the 
significant left SNc elevated QSM disappears with PD-MCI and PDD (Table 3.04). Note for the 
right SNc in PD-N the lower bound for the confidence interval is -0. This is because when the 
results were scaled up this value was found to be slightly less than zero, however when scaled 
back to the original units this small negative value was rounded to zero. The negative indicates 
that this confidence interval has in fact crossed zero. Due to the large volume of data in the 
category analysis just the left and right SNc is displayed in table 3.04. All the data is available in 
table A1, in Appendix A. 








Intercept 0.006 0.005 -0.005 0.016 
 
PDN 
Left SNc 0.02 0.008 0.005 0.037 
Right SNc 0.013 0.007 -0 0.028 
 
PD-MCI 
Left SNc 0.011 0.007 -0.001 0.025 
Right SNc 0.01 0.006 -0.001 0.023 
 
PDD 
Left SNc 0.001 0.008 -0.014 0.018 













































































































































Table 3.05: Summary of the trends between CogZ and mean QSM in each nuclei. A small, but significant increase in 
CogZ with increasing QSM was noted in the right RN.  
 
3.4 Additional Analyses 
The relationship between cognition and QSM was further investigated via the following model: 
qsm_model_cog <- brm(QSM_dm_su100 ~ Region:age_s100 + Region:sex + Region + 
Region:Group + cogz:Region + (1|nzbri_id), 
           control = list(adapt_delta = 0.99), 
           prior = c(set_prior("student_t(4,0,2)", class = "sd"), 
                     set_prior("student_t(4,0,2)", class = "sigma"), 
                     set_prior("student_t(3,0,1)", class = "b")), 
           data=w, algorithm = c("sampling")) 
summary(qsm_model_cog, waic = TRUE) 
 
This differs from the previous group model in 3.2 by the inclusion of a CogZ by region 
interaction, allowing the investigation of the association between QSM and global cognitive score 
in each region. This models cognition as a continuous variable as opposed to categories.  
Increased QSM in the SNc was found to persist with PD confirming the result from 3.2 (table A2, 
Appendix A). Additionally the left SNr also showed a significant increase, but this was borderline 
(table 3.05). There is a slight increase in CogZ with increasing mean QSM in the right RN, but 
























Intercept                       
0.006 0.005 -0.004 0.016 
Left caudate 
-0.003 0.003 -0.009 0.004 
Left GP 
-0.003 0.003 -0.009 0.004 
Left putamen 
-0.004 0.004 -0.011 0.003 
Left RN 
0.005 0.003 -0.002 0.012 
Left SNc 
0.002 0.004 -0.006 0.008 
Left SNr    
0.003 0.004 -0.004 0.010 
Left thalamus 
0.000 0.004 -0.007 0.007 
Right caudate 
0.002 0.003 -0.005 0.008 
Right GP          
-0.001 0.003 -0.008 0.006 
Right putamen  
-0.002 0.004 -0.009 0.004 
Right RN 
0.008 0.004 0.001 0.016 
Right SNc 
0.005 0.004 -0.002 0.012 
Right SNr 
0.006 0.004 -0.002 0.013 
Right thalamus 
0.000 0.004 -0.007 0.007 
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Figure 3.06a & b: a) Left SNc QSM (ppb) plotted against disease duration undertaken by Du et al 
(39)
. b) LSNc 
QSM (ppm) plotted against disease duration in years undertaken at the NZBRI. Unlike Du et al. our data 
appears to be no more than random scatter. 
The UPDRS-II and UPDRS-III models both came back with no correlations of statistical 
significance (Table A3 & 4, Appendix A). Disease duration also showed no trends of significance 









3.5 Whole Brain Analysis 
The whole brain analyses did not reveal any regions of statistical significance (p>0.095).  That is, 
no differences between groups or association with cognitive score survived correction for 
multiple comparisons. 
Chapter 4: Discussion 
4.1 Age and Sex Dependence 
There were some unexpected sex dependences on mean QSM discovered in the first analysis 
(table 3.01 & figure 3.01), which as far as I know have not been reported or discussed.  Although 
the estimates are small and borderline due to confidence interval’s proximity to zero, there may 
be some underlying physiological basis to this trend. 
There was a noticeable increase in mean QSM of the left and right putamen with age (fig. 3.02a 
& b), however this was found to be not significant. The BG can contain microbleeds which are 
hyperintense (paramagnetic) and calcifications which are hypointense (diamagnetic) and appear 
in QSM as white and black dots, respectively. Both are capable of creating significant outliers 
Du et al. NZBRI a) b) 
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that can affect the mean. Microbleeds in the putamen such as the one in fig. 4.1b are more 
common with age and may explain this age related trend in mean QSM in the putamen for the 















4.2 Group Analysis 
We saw an increase in the SNc mean QSM of PD compared to HC, which agrees with all 
previous studies of QSM and PD 
(38, 39, 40, 41, 42)
. This result effectively verifies that QSM has been 
correctly reconstructed and adequately analysed. As you can see in Fig 3.03a & b PD and HCs 
aren’t separated by very much in the SNc. Our estimates of the difference between mean QSM in 
left and right SNc for PD and HCs (~0.022 [0.008, 0.038]ppm ) was lower than that of Du et al. 
(0.04±0.04ppm) 
(39)
. Du also used a PD population that was in less advanced stages of the disease 
on average, which in theory would have led to a lower QSM group difference than what we 
obtained, however Du did not correct for multiple comparisons 
(39)
. Misalignment of SN masking 
in the current study may have also contributed to this difference. Variable SN masking may be 
due, in part, to the HC template not representing the entire population as a whole, residual 
coregistration and normalisation error that is significant when investigating a structure as small as 
the SN and the IXI555 template (healthy population with a mean age of ~23years) not fully 
Figure 4.1a & b: An example of microcalcification (a) and a microbleed (b), which are both related to 
cerebrovascular disease. Microcalcifications are small calcium deposits, which are quite strongly diamagnetic 
and appear black in QSM.  Microbleeds are small localised strokes and the blood that pools there is strongly 
paramagnetic. The QSM images have a window and level of 0.5 and -0.25. Images were obtained from the 




representing the population being studied (PD with a mean age 72 years). The controls were 
specifically used for the QSM template due to PD affecting the shape and size of the SN, which 
could then not be related to a healthy template like IXI555. Therefore the HCs offered the best 
estimate of an anatomical definition of the SN on the IXI555 template. Given that increasing 
QSM in the SN had already been correlated to PD progression and that partial voluming effects 
increases the size of high QSM structures it was believed that the SN and RN masks would 
inherently be within the confines of their respective structures for PD QSM 
(23, 40)
. However the 
resultant lack of accuracy in SN and RN masking in PD has probably occurred for the same 
reasons PD subjects were not used for the QSM template; there is most likely changes to the 
anatomy in PD due to neural atrophy 
(6)
. 
All the ROI studies performed thus far for QSM and PD had the nuclei investigated masked 
manually by an experienced radiologist either in the most representative slice 
(38, 40)
 or for the 
entire volume 
(39, 41)
 on QSM directly or using the template method and altering the masks after 
inverse normalisation 
(42)
 and as a result may be more accurate. While inverse normalization of 
SN and RN masks in normalized space have been used effectively in recent publications, hence 
our choice in using this method, manually-delineated SN and RN may have been more precise.  
It should also be noted whenever comparing past studies to this work that no other QSM study 
has used our method of statistical analysis, which may explain any discrepancy between the 
observed results in this study and others. The Bayesian regression model and correction for 
multiple comparisons is a much more accurate way of evaluating potential correlations 
(47)
. 
4.3 Category Analysis 
The category analysis yielded just a single significant increase in the left SNc for PD-N. The 
presence of a significant increase in mean QSM for PD-N, but a lack of this increase in SNc for 
PD-MCI and PDD indicates that there may be a secondary process occurring which may affect 
patients as dementia develops. However misalignment of SN & RN masks, as outlined in section 
4.2, has likely contributed to this difference including surrounding non-SN and RN tissues, which 
have likely reduced the mean QSM in these nuclei. From a masking point of view there is little 
ambiguity for the results of the caudate, GP, putamen and thalamus in our category analysis and 
hence the evidence we have gathered suggests that there is no correlation between QSM and 
cognition in these nuclei. 
Guan et al. noted an increase in the SNr and GP mean QSM (specifically the internal GP) in 
addition to the SNc in late PD (Hoehn & Yahr>3) 
(40)
. All of the PDD subjects in our population 
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had Hoehn and Yahr scores greater than 3, but we did not see these associations for PDD. SN 
masking misalignment likely accounts for the SNr and unfortunately, despite using much more 
accurate automatic segmentation for the GP, we did not differentiate between the internal and 
external GP. Other than not separating the GP one difference in methodology that could account 
for this discrepancy is the lack of correction for multiple comparisons in Guan’s study 
(40)
, 
however there are more sources of error in QSM itself, which should be taken into consideration: 
1. Field inhomogeneities or motion is capable of inducing arteficial phase shifts and signal. 
Because we are dealing with patients that have developed PD there will be some level of 
involuntary movement that we can’t realistically avoid. The involuntary movement can be 
partially treated, however the patients are in the scanner for almost an hour during which 
it is difficult to continue any medication and the time of QSM scanning within a session 
can vary.  
2. There is Gaussian noise in the receiver MRI coils. 
3. The thickness of our slices is quite significant leading to masking inaccuracies and 
averaging with tissues outside of the ROIs in the vicinity of nuclei boundaries. 
4. Levodopa dosage has shown a correlation with QSM but wasn’t corrected for in this 
study.  
5. The ill-posed nature of QSM reconstruction introduces a relatively high level of 
uncertainty. 
As a result the standard deviation of QSM was consistently around the 30% mark, which is 
normal for QSM 
(39)
. With a level of uncertainty this high significant variation can be expected 
between studies even with large sample sizes. 
Previous correlations in structures outside the SNc may have been due to using a single 
representative slice instead of averaging over the entire anatomical volume 
(40)
. Although single 
slice extraction can be seen as ‘cherry picking’ to some degree without physiological basis, it 
may be possible that iron deposition is localised within a nuclei and that averaging across the 
entire anatomical volume is simply averaging the deposition with other regions without any 
deposition and hence missing any potential markers of disease in that structure. There appears to 
be quite a lot of difference between the anatomical outlines of nuclei from T1 and those in QSM 
where nuclei are clearly visible (fig. 1.16c & d). Perhaps even though QSM is affected by partial 
voluming effects it may offer some extra insight into the deeper pathology of the disease. Perhaps 




The disappearance of the right SNc significant increase in QSM for PD-N may be due to 
asymmetry. PD in its early stages is asymmetrical with one side affected more than the other 
(6)
. 
The problem with grouping structures as left and right is the affected side varies. It’s possible that 
half the left structures of the brain are on the affected side and the other half are not blurring any 
potential differences between nuclei. Despite the asymmetrical onset of early PD Barbosa and He 
et al found no asymmetry in QSM between the affected and non-affected sides in early PD 
(Hoehn and Yahr<1) 
(38, 41)
.  Side affected data was available, but unfortunately it is unreliable 
due to its dependence on patient reports in many cases and is not available for every subject. The 
side affected analysis has another complication in that people are naturally left or right hand 
dominant and show asymmetry because of hand dominance without disease. When looking at 
which side is affected you also need to account for whether they are left or right handed, which 
wasn’t noted when our clinical trials were performed.   
4.4 Additional Analyses 
The CogZ model gave the same group based increase in the SNc as section 3.2 reaffirming this 
result. The CogZ model also returned a weak positive trend with mean QSM in the right RN. The 
RN has no known physiological role in cognition. Even so iron deposition and hence 
neurodegeneration with PD should lead to a reduction in cognition and therefore in CogZ 
resulting in a negative association not a positive association.  This result for CogZ is also likely to 
be influenced by misalignment of masking of the SN and RN already mentioned in section 4.2 
and 4.3.  
Unlike Du and He et al we did not see any correlations with UPDRS II or III 
(39, 41)
. A major 
factor in the discrepancy between our results and their findings is that we used a correction for 
multiple comparisons. It should also be noted that UPDRS-II and III clinical trials do also have 
some associated uncertainty. For UPDRS-II the results are somewhat subjective to the patient and 
for UPDRS-III the performance of the subject can vary from day to day due to random variation 
and mood 
(14)
. Different clinicians can also score the patients on UPDRS-III differently for 
reasons cited in section 1.04. 
Several studies have found a correlation between disease duration and QSM in the SNc, which 
we did not observe (fig.3.06a & b) 
(39, 41)
. A study by Jin et al. contradicted this finding noting no 
significant correlation between QSM and disease duration 
(50)
. This discrepancy was put down to 
differences in SN masking and hence our result is also likely affected by masking inaccuracies as 
outlined in section 4.2. 
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4.5 Whole Brain Analysis 
Acosta-Cabronero observed significant differences in QSM between PD and HCs in multiple 
regions of the brain including parts of temporal, paralimbic, occipto-parietal & prefrontal cortices 
as well as the rostral pontine area 
(42)
. Our results didn’t show any significance anywhere in the 
brain both for the PD and control group analysis and the CogZ analysis. Acosta-Cabronero also 
did not correct for multiple comparisons, but it is likely our results were affected by artefacts. 
There were a number of background field artefacts present around the border of the QSM images 
and where sinuses had been included in the brain mask by mistake that could not be avoided 
without manual intervention. The whole brain analysis is also very sensitive to co-registration 
errors, which could be improved 
(42)
. The reproducibility of the whole brain is unexplored and 
likely worse than any of the 7 nuclei we have investigated due to the inclusion of tissues in close 
proximity to the skull and air interfaces and hence the source of the background field. Extreme 
values on the fringe of the QS maps were quite frequently observed where brain masking had not 
quite excluded all tissues outside of the brain such as cerebrospinal fluid. 
4.6 Future developments 
As mentioned in section 4.1 cerebrovascular disease is capable of drastically altering QSM 
especially in the striatum and GP. This might explain why in fig. 3.05 the PDD category, where 
cerebrovascular disease is much more common, had a slightly lower QSM in the right and left 
caudate than the other categories. Ideally if these patients do have cerebrovascular disease they 
would be excluded, but there is a natural level of calcification and microbleeding with age and 
proper diagnosis is not at our disposal. Also cerebrovascular disease is most common in PDD, of 
which we only had 10 subjects (table 2.1). It is however possible to work around the disease. 
Both microbleeds and calcifications are highly localised and have distinct outlying values. It may 
be possible to exclude these pathologies from the means and medians of ROIs by finding the 
average minimum and maximum QSM in PD patients of varying PD severity and duration, but 
without cerebrovascular disease, and the standard deviation of these minimums and maximums, 
for each of the ROIs being investigated. Using the obtained minimum and maximum values one 
could form windows of the minimum -2 standard deviations to the maximum +2 standard 
deviations, and any values that are outside of this window such as cerebrovascular disease 
outliers could be excluded from the mean or median for that ROI. This would allow subjects with 
cerebrovascular disease that are predominantly PDD and who already have very limited 
availability to still be included in PD QSM research.  
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To clarify the effect of side affected on the category analysis, especially for early PD, a 
sideaffected analysis accounting for left and right hand dominance should be undertaken with 
correction for multiple comparisons. Also analysing the internal and external GP individually in 
the category model may reveal a positive correlation with QSM such as that discovered by Guan 
et al., which may be related to cognition 
(40)
.  
We were unable to reproduce the 
contrast present in the T1 template 
Acosta-Cabronero used when he 
separated the SN. Using the IXI555 
template I could make out a rough 
darker area on the outside of the 
transverse view (fig2.03c), a lighter 
band in between before the RN, but it 
was nothing like Acosta-Cabronero’s 
template (fig 4.2) and it was of lower 
resolution. Using Acosta-
Cabronero’s template could provide 
a better idea of the spatial position of 
the SNc and SNr and improve these 
masks. Alternatively the inverse 
warped SN and RN masks could be 
manually altered to ensure they 
match up with the equivalent structure on the individual subject’s normalized QSM providing 
more accurate estimates of mean QSM in the SN and RN 
(42)
. It would be useful to repeat our 
analyses with single slice manually drawn masks for each structure to see if we get the same 
results as the other single slice studies. Also better brain masks may be able to reduce artefacts 
present in the whole brain analysis along with improved coregistration.  
Iron concentration and therefore mean QSM has been correlated to PD duration and is seen to be 
significantly higher in the SNc of early PD patients then in HC 
(41)
. These findings along with the 
fact that 50-80% of SNc cell loss occurs before any PD symptoms even arise means that it is 
likely that iron accumulation and elevated iron concentration in the SNc can be detected before 
PD even develops or shows symptoms 
(6)
. If the relationship between iron deposition and SNc 
cell loss is linear prior to disease development and is significantly higher than that of healthy 
individuals this would give rise to the possibility of forming a PD prognosis with QSM, which 
Figure 4.2: Acosta-Cabronero’s T1 template and overlaid SNc 
(yellow) and SNr (red) masks. A is the T1 template, B is a 
magnitude image template, and C is the QSM template. Note that 
the contrast and appearance of the SNr and SNc in A is greatly 






would allow the trial and application of an intervention to prevent PD progression. There are 
several interventions already being proposed including iron chelators, which became the first 
therapy found to delay PD progression 
(51)
.  
Santin et al tested various QSM techniques to check the reproducibility of QSM and found the 
within and between subject variation due to set up differences, and individual variability to be 
sufficiently small as to enable longitudinal studies with realistic populations 
(37)
. However with 
only 1% of the population over 60 developing PD, to prove that PD can be predicted by SNc 
QSM you would need a longitudinal study of the order of several thousand healthy individuals to 
achieve a large enough PD sample size to be able to prove there is a correlation and analyse its 
significance 
(4, 37)
. Also the subjects used in Santin’s study were healthy and hence did not take 
into account reduced reproducibility due to motion of PD patients during scanning 
(37)
. With 
involuntary tremors motion is practically inevitable and unavoidable even if treated with 
medication so this would need to be investigated to be sure that QSM in PD is adequately 
reproducible for longitudinal PD tracking. 
Chapter 5: Conclusion 
In conclusion we have found significant increases in the left and right SNc in PD when compared 
to healthy age and sex matched controls, which agrees with the literature. From the evidence we 
have gathered there doesn’t seem to be any association between QSM and cognition. We did not 
observe a disease duration correlation for SNc, which disagrees with the literature and the weak 
correlation found between CogZ and QSM was the opposite of what we expected in terms of the 
known physiology, however differences in the statistical analyses used in this study and others 
may account for the discrepancies observed. It is likely that any correlations in the SN and RN 
are influenced by poor masking. In the future we hope to improve the SN & RN masking and 
further investigate the impact of single slice masking and separation of the GP into its internal 
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Appendix A: Additional Analyses 























Left caudate -0.004 0.006 -0.016 0.008 
Left GP -0.001 0.006 -0.013 0.012 
Left putamen -0.003 0.006 -0.016 0.009 
Left RN 0.008 0.007 -0.005 0.022 
Left SNc 0.020 0.008 0.005 0.037 
Left SNr    0.011 0.007 -0.003 0.026 
Left thalamus -0.004 0.006 -0.017 0.009 
Right caudate -0.005 0.006 -0.019 0.007 
Right GP          0.000 0.006 -0.013 0.012 
Right putamen  -0.003 0.006 -0.016 0.009 
Right RN 0.002 0.007 -0.012 0.015 
Right RSNc 0.013 0.007 -0.000 0.028 
Right SNr 0.004 0.007 -0.009 0.017 















Left caudate -0.003 0.006 -0.014 0.008 
Left GP 0.000 0.006 -0.011 0.012 
Left putamen -0.005 0.006 -0.017 0.005 
Left RN -0.007 0.006 -0.020 0.004 
Left SNc 0.011 0.007 -0.001 0.025 
Left SNr    0.004 0.006 -0.008 0.016 
Left thalamus -0.005 0.006 -0.017 0.006 
Right caudate -0.006 0.006 -0.017 0.005 
Right GP          0.004 0.006 -0.007 0.016 
Right putamen  -0.003 0.006 -0.015 0.008 
Right RN -0.009 0.006 -0.021 0.003 
Right RSNc 0.010 0.006 -0.001 0.023 
Right SNr 0.002 0.006 -0.009 0.013 








Left caudate -0.001 0.008 -0.017 0.014 
Left GP 0.003 0.008 -0.012 0.02 
Left putamen -0.003 0.008 -0.019 0.013 
Left RN -0.006 0.008 -0.024 0.009 
Left SNc 0.001 0.008 -0.014 0.018 
Left SNr    0.000 0.008 -0.015 0.016 










Right caudate -0.004 0.008 -0.021 0.011 
Right GP          0.006 0.009 -0.010 0.024 
Right putamen  -0.003 0.008 -0.019 0.012 
Right RN 0.005 0.008 -0.023 0.011 
Right RSNc -0.001 0.008 -0.017 0.015 
Right SNr 0.005 0.008 -0.022 0.010 
Right thalamus 0.004 0.008 -0.012 0.021 










Intercept 0.006 0.005 -0.004 0.016 
Left caudate -0.006 0.006 -0.018 0.005 
Left GP -0.001 0.006 -0.014 0.011 
Left putamen -0.011 0.007 -0.026 0.002 
Left RN 0.005 0.007 -0.008 0.018 
Left SNc 0.024 0.008 0.009 0.040 
Left SNr 0.015 0.007 0.001 0.030 
Left thalamus -0.006 0.007 -0.020 0.006 
Right caudate -0.007 0.007 -0.021 0.005 
Right GP 0.001 0.007 -0.012 0.014 
Right putamen -0.009 0.007 -0.023 0.003 
Right RN 0.005 0.007 -0.008 0.020 
Right RSNc 0.023 0.008 0.008 0.038 
Right SNr 0.010 0.007 -0.004 0.024 
Right thalamus -0.004 0.007 -0.017 0.009 

















Intercept                         0.002 0.005 -0.009 0.012 
Left caudate -0.001 0.012 -0.026 0.023 
Left GP 0.005 0.013 -0.017 0.038 
Left putamen 0.001 0.012 -0.022 0.027 
Left RN 0.003 0.012 -0.020 0.031 
Left SNc 0.010 0.016 -0.013 0.050 
Left SNr    0.007 0.015 -0.016 0.041 
Left thalamus -0.001 0.012 -0.026 0.023 
Right caudate -0.005 0.013 -0.036 0.019 
Right GP          -0.001 0.013 -0.029 0.023 
Right putamen  -0.001 0.012 -0.027 0.023 
Right RN -0.004 0.013 -0.034 0.019 
Right SNc -0.003 0.013 -0.032 0.021 
Right SNr -0.004 0.013 -0.033 0.019 
Right thalamus 0.000 0.012 -0.025 0.025 





















Intercept                         0.002 0.005 -0.008 0.012 
Left caudate 0.011 0.016 -0.014 0.051 
Left GP 0.005 0.013 -0.018 0.035 
Left putamen -0.005 0.014 -0.037 0.020 
Left RN 0.001 0.012 -0.022 0.025 
Left SNc -0.002 0.012 -0.028 0.022 
Left SNr    0.001 0.013 -0.024 0.028 
Left thalamus -0.003 0.013 -0.029 0.020 
Right caudate 0.002 0.013 -0.023 0.029 
Right GP          0.001 0.012 -0.024 0.025 
Right putamen  -0.007 0.015 -0.044 0.017 
Right RN -0.003 0.013 -0.032 0.021 
Right SNc -0.008 0.015 -0.044 0.016 
Right SNr 0.002 0.012 -0.023 0.027 
Right thalamus 0.002 0.005 -0.008 0.012 




















Intercept                         
0.001 0.005 -0.009 0.012 
Left caudate 
-0.002 0.013 -0.029 0.024 
Left GP 
0.007 0.015 -0.017 0.042 
Left putamen 
-0.007 0.013 -0.040 0.015 
Left RN 
0.013 0.018 -0.014 0.062 
Left SNc 
0.007 0.015 -0.016 0.044 
Left SNr    
-0.004 0.013 -0.033 0.019 
Left thalamus 
-0.001 0.013 -0.028 0.023 
Right caudate 
-0.007 0.015 -0.046 0.016 
Right GP          
0.004 0.013 -0.018 0.036 
Right putamen  
-0.003 0.013 -0.031 0.020 
Right RN 
0.002 0.013 -0.023 0.028 
Right SNc 
0.004 0.013 -0.019 0.035 
Right SNr 
-0.009 0.015 -0.045 0.016 
Right thalamus 
-0.005 0.014 -0.035 0.019 
Table A5: Results of the disease duration model for mean QSM. 
 
 
 
 
 
 
 
 
 
 
 
